» Articles » PMID: 8039602

Aldose Reductase Catalysis and Crystallography. Insights from Recent Advances in Enzyme Structure and Function

Overview
Journal Diabetes
Specialty Endocrinology
Date 1994 Aug 1
PMID 8039602
Citations 12
Authors
Affiliations
Soon will be listed here.
Abstract

Enhanced metabolism of glucose via the polyol pathway may play an important role in the pathogenesis of diabetic retinopathy, neuropathy, and nephropathy. Aldose reductase catalyzes the NADPH-dependent conversion of glucose to sorbitol, the first step in the polyol pathway. Interruption of the polyol pathway by inhibition of aldose reductase holds considerable promise as a therapeutic measure to prevent or delay the onset and severity of these late complications of diabetes. Dramatic advances in our understanding of the molecular biology, enzymology, and three-dimensional structure of aldose reductase have occurred in recent years, providing new and challenging insights into the enzyme's catalytic mechanism. Recent developments in structure determination of aldose reductase and the implications for evaluation and development of aldose reductase inhibitors are summarized.

Citing Articles

Aldose Reductase: An Emerging Target for Development of Interventions for Diabetic Cardiovascular Complications.

Jannapureddy S, Sharma M, Yepuri G, Schmidt A, Ramasamy R Front Endocrinol (Lausanne). 2021; 12:636267.

PMID: 33776930 PMC: 7992003. DOI: 10.3389/fendo.2021.636267.


Design of an amide N-glycoside derivative of β-glucogallin: a stable, potent, and specific inhibitor of aldose reductase.

Li L, Chang K, Zhou Y, Shieh B, Ponder J, Abraham A J Med Chem. 2013; 57(1):71-7.

PMID: 24341381 PMC: 3956592. DOI: 10.1021/jm401311d.


Aldose reductase, oxidative stress and diabetic cardiovascular complications.

Vedantham S, Ananthakrishnan R, Schmidt A, Ramasamy R Cardiovasc Hematol Agents Med Chem. 2012; 10(3):234-40.

PMID: 22632267 PMC: 3629910. DOI: 10.2174/187152512802651097.


Aldose reductase and cardiovascular diseases, creating human-like diabetic complications in an experimental model.

Ramasamy R, Goldberg I Circ Res. 2010; 106(9):1449-58.

PMID: 20466987 PMC: 2882633. DOI: 10.1161/CIRCRESAHA.109.213447.


The polyol pathway as a mechanism for diabetic retinopathy: attractive, elusive, and resilient.

Lorenzi M Exp Diabetes Res. 2008; 2007:61038.

PMID: 18224243 PMC: 1950230. DOI: 10.1155/2007/61038.